Abstract
Thein vivo binding kineties of11C-iomazenil were compared with those of11C-flumazenll binding in rhesus monkey brain. The monkey was anesthetized with ketamine and intravenously injected with either11C-iomazenil or11C-flumazenil in combination with the coadministration of different doses of non-radioactive flumazenil (0,5 and 20 μg/kg).
The regional distribution of11C-iomazenil in the brain was similar to that of11C-flumazenil, but the sensitivity of11C-iomazenil binding to competitive inhibition by non-radioactive flumazenil was much less than that of11C-flumazenil binding. A significant reduction in11C-flumazenil binding in the cerebral cortex was observed with 20 μg/kg of flumazenil, whereas a relatively smaller inhibition of11C-iomazenil binding in the same region was observed with the same dose of flumazenil. These results suggest that11C-flumazenil may be a superior radiotracer for estimating benzodiazepine receptor occupancy in the intact brain.
Similar content being viewed by others
References
Hosoi R, Kobayashi K, Watanabe Y, Inoue O. Discrepancy of benzodiazepine receptor occupancy between3H flumazenil and125I-iomazenil in intact mouse brain.J Neural Transm 1999; 106: 243–256.
Suzuki K, Inoue O, Tamate K, Mikado F. Production of 3-N-[11C]methylspiperone with high specific activity and high radiochemical purity for PET studies: suppression of its radiolysis.Int J Rad Appl Instrum 1990; 41: 593–599.
Onoe H, Inoue O, Suzuki K, Tsukada H, Itoh T, Mataga N, et al. Ketamine increases the striatalN-[11C]methylspiperone bindingin vivo: positron emission tomography study using conscious rhesus monkey.Brain Res 1994; 663: 191–198.
Persson A, Ehrin E, Eriksson L, Farde L, Hedstrom CG, Litton JE, et al. Imaging of [11C]-labelled Ro 15–1788 binding to benzodiazepine receptors in the human brain by positron emission tomography.J Psychiatr Res 1985; 19: 609–622.
Inoue O, Kobayashi K, Takai N, Furusawa Y, Ando K, Nakano T, et al. An increase in [3H]QNB binding by protonbeam írradiation in intact rat brain: an apparent positive cooperativity of binding.Neurosci Lett 1998; 250: 33–36.
Inoue O, Kobayashi K, Gee A. Changes in apparent rates of receptor binding in the intact brain in relation to the heterogeneity of reaction environments.Crit Rev Neurobiol 1999; 13: 199–225.
Videbaek C, Ott P, Paulson OB, Knudsen GM. Blood-brain barrier transport and protein binding of flumazenil and iomazenil in the rat: implications for neuroreceptor studies.J Cereb Blood Flow Metab 1999; 19: 948–955.
Inoue O, Wakahara S, Kobayashi K, Gee A. Enhancement of3H-N-methylspiperone binding but not3H-raclopride binding in mouse striatum by MK-801: evidence that factors other than competition by endogenous dopamine are responsible for changes in D2 receptor bindingin vivo.J Neural Transm 1999; 106: 131–137.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Inoue, O., Hosoi, R., Kobayashi, K. et al. Different sensitivities to competitive inhibition of benzodiazepine receptor binding of11C-iomazenil and11C-flumazenil in rhesus monkey brain. Ann Nucl Med 15, 137–139 (2001). https://doi.org/10.1007/BF02988604
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02988604